Nigel Baker

Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer

Andrew Tutt, Judy E. Garber, Bella Kaufman et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Z. Mark, Petr Zatloukal et al. · Journal of Clinical Oncology · 2011 · 243 citations · Full text

Effect of Darbepoetin Alfa on Exercise Tolerance in Anemic Patients With Symptomatic Chronic Heart Failure

Piotr Ponikowski, Stefan D. Anker, Joanna Szachniewicz et al. · Journal of the American College of Cardiology · 2007 · 208 citations

Exercise Tolerance, Heart Failure, Darbepoetin Alfa +9

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

Dirk J. van Veldhuisen, Kenneth Dickstein, A Cohen-Solal et al. · European Heart Journal · 2007 · 194 citations · Full text

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients

Yves Vanrenterghem, Peter Bárány, Johannes F.E. Mann et al. · Kidney International · 2002 · 174 citations

Hemodialysis, Urology, Darbepoetin Alfa +9